Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
04/2009
04/07/2009US7514457 Substituted aryloxymethyl bicyclicmethyl acetamide compounds
04/02/2009US20090088570 Organic electroluminescent device
04/01/2009EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists
04/01/2009EP2041096A1 2-amino benzimidazole derivatives and their use as modulators of small- conductance calcium-activated potatium channels
04/01/2009EP1673348B1 Benzoimidazole compounds
04/01/2009CN101397276A Dibenzimidazole and onium compound thereof, preparation method and medical use thereof
04/01/2009CN101397275A Method for preparing 2-( p-aminophenyl) benzimidazole-5-amine
03/2009
03/31/2009US7511153 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof
03/26/2009WO2009038847A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
03/26/2009US20090082416 Deuterium-enriched bendamustine
03/26/2009US20090082395 Soluble epoxide hydrolase inhibitors
03/26/2009US20090079343 Organic electroluminescent device
03/26/2009CA2691031A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
03/25/2009EP2039693A2 Novel synthesis of irbesartan
03/25/2009EP2038274A2 Transcription factor modulating compounds and methods of use thereof
03/25/2009EP2038259A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
03/25/2009EP1991514A4 Novel anthracene derivative and organic electronic device using the same
03/25/2009CN101391982A Alkylation reaction method of benzimidazoles compounds
03/25/2009CN100471930C Organic electroluminescent material, organic electroluminescent device and hetrocycle-containing iridium complex compound
03/24/2009US7507755 Inhibitors of cathepsin s
03/19/2009WO2009035951A2 Soluble epoxide hydrolase inhibitors
03/19/2009WO2009034061A1 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter
03/19/2009WO2009034028A2 Novel compounds
03/19/2009US20090076279 Reaction products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives
03/19/2009US20090076106 2-(Phenylamino) Benzimidazole Derivatives and Their Use as Modulators of Small- Conductance Calcuim-Activated Potassium Channels
03/19/2009US20090075938 Treatment of duchenne muscular dystrophy
03/18/2009EP2035409A1 Benzimidazole derivatives which are to be used as anatgonist for the cb1-receptor
03/18/2009EP2035401A2 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/18/2009EP2035370A2 Tetralin and indane derivatives and uses thereof
03/18/2009EP1689380A4 Method for treating adamts-5-associated disease
03/18/2009EP1386912B1 Cyclic amidine derivative
03/18/2009CN101389684A Curable epoxy resin composition
03/18/2009CN101389610A Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504426 Antiallergens; rhitinis; antiinflammatory agents
03/17/2009US7504422 Polyamine compounds
03/17/2009US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
03/17/2009US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
03/17/2009US7503973 Nanosized particles of benzimidazolone pigments
03/12/2009WO2009030750A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use
03/12/2009WO2009030747A1 Derivatives of n-phenylacetamide, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
03/12/2009US20090069570 Anti-malignant tumor agent, diarrheal irritable bowel syndrome; 5-HT3 receptor antagonist; reacting (R)-4,5,6,7-tetrahydro-1H-benzimidazole-5-carboxylic acid with a halogenation agent, and then with 1-methyl-1H-indole in the presence of diethylaluminum chloride or ethylaluminum sesquichloride
03/12/2009US20090069341 Inhibitors of hsp90
03/12/2009US20090069322 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections
03/12/2009US20090068699 Use of glutaminyl cyclase inhibitors
03/12/2009CA2698306A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use
03/12/2009CA2698299A1 Derivatives of n-phenylacetamide, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
03/11/2009EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity
03/11/2009EP2032541A2 Novel viral replication inhibitor
03/11/2009CN101384560A Nitrogenous heterocycle derivative, and organic electroluminescent element employing the same
03/11/2009CN101384559A Benzimidazole derivatives and their use for modulating the GABA-A receptor complex
03/11/2009CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same
03/10/2009US7501526 Synthesis of polyamine compounds
03/10/2009US7501525 Derivatives of benzimidazole and their use as medicaments
03/10/2009US7501524 Melacocortin receptors; analgesics; antiinflammatory agents; eating disorders; psychological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents
03/10/2009US7501448 high yields, low cost process; easy solvent extraction; nontoxic, safe, environmentally friendly, low boiling point organic solvents; 1,7'-dimethyl-2'-propyl-1H,3'H-[2,5']bibenzoimidazolyl is reacted with 4'bromomethyl-biphenyl-2-carboxylic acid alkyl ester; industrial scale; hydrolysis
03/10/2009US7501447 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
03/10/2009CA2377233C Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
03/05/2009WO2009027614A2 Method for splitting omeprazole salts
03/05/2009WO2009027264A1 Benzimidazole derivatives used as fxr agonists
03/05/2009WO2009026701A1 Sirtuin inhibitors
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062363 Amide derivative or salt thereof
03/05/2009US20090062360 Compounds Which Inhibit the Glycine Transporter and Uses Thereof
03/05/2009US20090062356 Substituted benzimidazole derivatives
03/05/2009US20090062268 Novel inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009US20090060838 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
03/05/2009CA2697724A1 Method for splitting omeprazole salts
03/05/2009CA2697167A1 Benzimidazole derivatives used as fxr agonists
03/04/2009CN101379041A Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
03/04/2009CN100465173C A selective kinase inhibitor
03/03/2009US7498439 Synthesis of heteroaryl acetamides from reaction mixtures having reduced water content
03/03/2009US7498354 Pyrrolo[2,3-D]imidazoles for the treatment of hyperproliferative disorders
02/2009
02/26/2009WO2009025358A1 Heterocyclic compound and use thereof
02/26/2009WO2009025265A1 Piperazine derivative
02/26/2009WO2009024287A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
02/26/2009US20090054652 Cyanine Compound and Optical Recording Material
02/26/2009US20090054479 Fused heterocyclic derivatives as ppar modulators
02/26/2009US20090054432 2-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA Inhibitors
02/26/2009US20090054431 Novel heterocycle compounds
02/26/2009US20090054235 Benzoheterocyclylethylbenzamide derivatives
02/26/2009US20090053826 Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers
02/26/2009US20090053742 Capture and release based isotope tagged peptides and methods for using the same
02/26/2009CA2696693A1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
02/25/2009EP2027098A1 1-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro (4.5)dec-3-en-2-one derivatives and their use as glycine transporter inhibitors
02/25/2009EP2027097A1 Improved monomers and polymers carrying imidazole and benzimidazole groupings, and proton exchange membrane containing the same for the production of a fuel cell
02/24/2009US7495110 Benzimidazole derivatives and their use as GnRH antagonists
02/24/2009US7495109 Nociceptin analogs
02/19/2009WO2008018827A8 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders
02/19/2009US20090048321 Benzimidazole Derivatives and Their Use for Modulating the GABA-Alpha Receptor Complex
02/19/2009US20090048300 Heterocyclic Compounds
02/19/2009DE102007037579A1 Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe New benzimidazol-2-yl-alkylamines and their application as microbicidal agents
02/18/2009EP2024336A1 Novel pharmaceutical compositions
02/18/2009EP1017674B1 Utilizing spirocyclic phenyl keto-enols as pesticides and herbicides
02/18/2009CN101370787A 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
02/17/2009US7491741 Diaminopropionic acid derivatives
02/17/2009US7491733 Bicyclic guanidine derivatives and therapeutic uses thereof
02/12/2009WO2009020225A1 Modified polymer complex, complex monomer, polymer complex, and redox catalyst
02/12/2009WO2009019506A1 Heterocyclyc sulfonamides having edg-1 antagonistic activity
02/12/2009WO2009019149A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 154